| Literature DB >> 35811632 |
Zhuo Yang1, Ting Ni1, Yan Yang1, Hui Zhang1, Hongli Chi1.
Abstract
Objective: This study aims to select and summarize the best evidence of temperature management for comatose patients after cardiopulmonary resuscitation in intensive care units (ICUs) at home and abroad. Method: Some well-known databases at home and abroad have been searched to find the guidelines, expert consensus, original documents, evidence summaries, and systematic evaluation about temperature management for comatose patients after cardiopulmonary resuscitation in ICUs. The databases included PubMed, Up to Date, Cochrane Library, the website of Registered Nurses' Association of Ontario, the Guideline Library of National Institute for Health and Clinical Excellence of the UK, China National Knowledge Infrastructure (CNKI), Wanfang Database, and VIP. The period for search is from the establishment of each database to the present. Two researchers who have received evidence-based nursing training and passed the examination evaluated, extracted, and integrated the literature quality with a blind method to summarize the best evidence.Entities:
Year: 2022 PMID: 35811632 PMCID: PMC9262552 DOI: 10.1155/2022/2220487
Source DB: PubMed Journal: Appl Bionics Biomech ISSN: 1176-2322 Impact factor: 1.664
Figure 1Flow chart of literature inclusion.
General description of the included literature.
| Author | Year of publication | Title | Type | Source | Language | Quality evaluation |
|---|---|---|---|---|---|---|
| Hu Chunlin, et al. [ | 2009 | Meta-analysis of mild hypothermia therapy in cardiopulmonary resuscitation after cardiac arrest | Systematic evaluation | Wanfang Database | Chinese | Qualified |
| Yu Tao et al. [ | 2011 | Advances in hypothermia therapy during cardiopulmonary resuscitation | Literature review | CNKI | Chinese | Qualified |
| American Heart Association [ | 2015 | Web-based integrated guidelines for cardiopulmonary resuscitation and emergency cardiovascular care– part 8:post-cardiac arrest care | Guideline | PubMed | English | Qualified |
| Nolan et al. [ | 2015 | European Resuscitation Council and European Society of Intensive Care Medicine guidelines for post-resuscitation care 2015:section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015 | Guideline | PubMed | English | Qualified |
| ARC [ | 2016 | ANZCOR Guideline 1 1.8 – targeted temperature management (TTM) after cardiac arrest | Guideline | Cochrane Library | English | Qualified |
| Howes et al. [ | 2016 | Canadian Guidelines for the use of targeted temperature management (therapeutic hypothermia) after cardiac arrest: a joint statement from The Canadian Critical Care Society (CCCS), Canadian Neurocritical Care Society (CNCCS), and the Canadian Critical Care Trials Group (CCCTG) | Comparative experiment | The website of Registered Nurses' Association of Ontario | English | Qualified |
| Geocadin et al. [ | 2017 | Practice guideline summary: reducing brain injury following cardiopulmonary resuscitation: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology | Guideline | PubMed | English | Qualified |
| Cariou et al. [ | 2017 | Targeted temperature management in the ICU: guidelines from a French expert panel | Expert consensus | Up to Date | English | Qualified |
| Zhang Yuman et al. [ | 2020 | Summary of the best evidence of target body temperature management for patients with cardiac arrest | Evidence summary | Wanfang Database | Chinese | Qualified |
| Song Chunxia et al. [ | 2021 | Quality evaluation of target body temperature management guidelines for patients with cardiac arrest | Evidence summary | VIP | Chinese | Qualified |
Figure 2Funnel plot for analysis of publication bias in the included literature.
Best evidence summary of temperature management for comatose patients after cardiopulmonary resuscitation in ICUs.
| Item | Evidence | Recommendation grade |
|---|---|---|
| Mild hypothermia therapy | Indications: Mild hypothermia therapy should be implemented as soon as possible for adult patients who recover spontaneous circulation but are still in a coma after cardiac arrest. | Grade A |
| Contraindications: No absolute contraindications. The relative contraindications include severe infection, uncontrollable bleeding, and intractable shock. | Grade A | |
| Place of implementation: With necessary support, it can be initiated in pre-hospital settings, emergencyrooms, and ICUs. | Grade A | |
| Implementation personnel: It is recommended that the on-site medical staff who have received the training on mild hypothermia therapy start the treatment as soon as possible without the specialist consultation. | Grade A | |
| Start time: It should be initiated within 6 hours after the recovery of autonomic circulation, and the earlier, the better. If inevitable delay occurs due to various reasons, it may still be beneficial within 8 or more hours after the recovery of autonomic circulation. | Grade A | |
| Target temperature: 33°C (32°C-34°C) is recommended for patients in a deep coma, or with evidence of brain edema or malignant EEG waveform. Otherwise, the recommended temperature is <36°C (32°C-36°C). | Grade B | |
| Cooling measures: The whole-body hypothermia technique with temperature feedback control device or intravascular hypothermia technique or locally induced hypothermia (head) which gradually spreads to the whole body. If the medical conditions are undesirable, ice blanket, ice cap, and other treatments can be used. In case of cardiac insufficiency or risk of pulmonary edema, be careful to use 4°C normal saline intravenous infusion for induction. | Grade B | |
| Duration of induced hypothermia: The target temperature shall be reached as soon as possible, and the recommended duration is 2-4 hours. | Grade B | |
| Duration of hypothermia maintenance: 24 hours are recommended. | Grade B | |
| Temperature monitoring method: Bladder or rectum temperature monitoring is the first choice, and nasopharynx, esophagus, bladder, endotracheal tube cuff, and pulmonary artery are recommended as the core monitoring sites. | Grade A | |
| Interruption of mild hypothermia therapy: It is recommended to interrupt mild hypothermia therapy for patients with unstable hemodynamics, ineffective active resuscitation, and severe bleeding during treatment | Grade B | |
| Rewarming | Rewarming speed: 0.25°C-0.5 °C/h is recommended | Grade B |
| Temperature requirement after rewarming: <37.5 °C | Grade B | |
| Duration of maintenance after rewarming: Rewarming shall be maintained until 72 hours after resuscitation | Grade B | |
| Prevention of mild hypothermia-related complications | Evaluation and control of shivering: Bedside shivering assessment scale (BSAS) and continuous EEG monitoring assessment are selected. It is recommended to administrate muscle relaxant buspirone (load: 30 mg; maintenance dose: 15 mg, once every 8 h), midazolam (load: 0.1 mg/kg; maintenance dose: 2-6 mg/h) and pethidine hydrochloride (load: 1 mg/kg; maintenance dose: 25-45 mg/h) alone or in combination. If shivering is not controlled as expected or rapid cooling occurs, vecuronium bromide (load: 0.03-0.05 mg/kg; maintenance dose: 0.02-0.03 mg/kg·h) or rocuronium bromide (load 0.6 mg/kg, maintenance dose 0.3-0.6 mg/kg·h) should be added. It is not recommended to routinely use anticonvulsant drugs to prevent epilepsy. At the same time, active body surface warming should be made and sedation and analgesia should be provided. | Grade B |
| Monitoring and treatment of arrhythmia: Monitor ECG, carefully use drugs that can prolong QTc interval, and use antiarrhythmic drugs for arrhythmias that are malignant or seriously affect hemodynamics. If bradycardia occurs, routine treatment is not recommended unless it leads to hemodynamic instability. | Grade B | |
| Monitoring and control of infection: It is not allowed to use procalcitonin to diagnose infection during mild hypothermia therapy, and antibiotics are also prohibited. It is recommended to operate in strict accordance with disinfection procedures. | Grade B | |
| Monitoring of serum potassium level: The recommended serum potassium level is >3.0 mmol/L. | Grade B | |
| Prevention of other complications: Low metabolic rate, abnormal blood glucose, cold diuresis, hemodynamic instability, coagulation disorder, and decreased drug clearance may occur. Therefore, the patients should be closely monitored and actively treated. | Grade B | |
| Nutritional support | Enteral nutrition: Enteral nutrition support is recommended during mild hypothermia therapy. | Grade A |
| Energy intake: It is recommended to keep the energy intake up to 75% of the target value under normal body temperature during mild hypothermia therapy. | Grade B |
Note: Grade A indicates strong recommendation; Grade B indicates recommendation.